St. Jude Children's Research Hospital
Welcome to AAP 2019! Please stop by St. Jude Booth 645!
Since its founding in 1962, St. Jude Children’s Research Hospital has played a pivotal role in pushing overall U.S. pediatric cancer survival rates from 20 to more than 80 percent. This year, St. Jude was once again named one of the top hospitals for pediatric cancer in U.S. News and World Report’s 2019-2020 list of Best Children’s Hospitals. The only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children, St. Jude creates more clinical trials for cancer than any other children’s hospital and specializes in treating children with aggressive cancers that may not respond to standard treatments. St. Jude accepts most patients based on their ability to enroll in an open clinical trial. Children and young adults with newly diagnosed or suspected pediatric cancer, HIV infections or certain hematologic or genetic diseases that St. Jude treats may be eligible. Clinicians may stay up to date on open research protocols by subscribing to the monthly email newsletter, "Clinical Trials Alert". Visit our website, www.stjude.org for more information.